Journal of Immunology Research
Volume 2017 (2017), Article ID 7869412, 1 page
https://doi.org/10.1155/2017/7869412

Erratum

Erratum to “Low Baseline Interleukin-17A Levels Are Associated with Better Treatment Response at 12 Weeks to Tocilizumab Therapy in Rheumatoid Arthritis Patients”

Sang Jin Lee,1,2 Won Park,³ Sung Hwan Park,⁴ Seung-Cheol Shim,⁵ Han Joo Baek,⁶ Dae-Hyun Yoo,⁷ Hyun Ah Kim,⁸ Soo Kon Lee,⁹ Yun Jong Lee,¹⁰ Young Eun Park,¹¹ Hoon-Suk Cha,¹² Jin Kyun Park,1,2 Eun Young Lee,¹ Eun Bong Lee,¹ and Yeong Wook Song1,2

¹Division of Rheumatology, Seoul National University Hospital, Seoul, Republic of Korea
²Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology and College of Medicine, Medical Research Institute, Seoul National University, Seoul, Republic of Korea
³Division of Rheumatology, Inha University Hospital, Incheon, Republic of Korea
⁴Division of Rheumatology, The Catholic University of Korea Seoul St. Mary’s Hospital, Seoul, Republic of Korea
⁵Division of Rheumatology, Eulji University Hospital, Daejeon, Republic of Korea
⁶Division of Rheumatology, Gachon University Gil Medical Center, Incheon, Republic of Korea
⁷Division of Rheumatology, Hanyang University Medical Center, Seoul, Republic of Korea
⁸Division of Rheumatology, Hallym University Medical Center, Anyang, Republic of Korea
⁹Division of Rheumatology, Yonsei University Health System, Seoul, Republic of Korea
¹⁰Division of Rheumatology, Seoul National University Bundang Hospital, Seongnam, Republic of Korea
¹¹Division of Rheumatology, Pusan National University Hospital, Busan, Republic of Korea
¹²Division of Rheumatology, Samsung Medical Center, Seoul, Republic of Korea

Correspondence should be addressed to Yeong Wook Song; ysong@snu.ac.kr

Received 20 June 2017; Accepted 2 July 2017; Published 20 August 2017

Copyright © 2017 Sang Jin Lee et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

In the article titled “Low Baseline Interleukin-17A Levels Are Associated with Better Treatment Response at 12 Weeks to Tocilizumab Therapy in Rheumatoid Arthritis Patients” [1], the name of the ninth author was given incorrectly as Yun Jong Leee. The author’s name should have been written as Yun Jong Lee. The revised authors’ list is shown above.

References

S. J. Lee, W. Park, S. H. Park et al., “Low baseline interleukin-17A levels are associated with better treatment response at 12 weeks to tocilizumab therapy in rheumatoid arthritis patients,” Journal of Immunology Research, vol. 2015, Article ID 487230, 7 pages, 2015.